CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME PATIENTS WITH CYP2Y12*2 AND CYP2Y12*3 POLYMORPHISMS

QR Code

CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME PATIENTS WITH CYP2Y122 AND CYP2Y123 POLYMORPHISMS

Aim. This study aimed to look at the characteristics of the P2Y12 reactivity unit (PRU) in 30 Minang acute coronary syndrome (ACS) patients in Dr. M. Djamil Hospital, Padang, Indonesia.Material and methods. This research was a cross-sectional study conducted in September 2016. The effectiveness of c...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. Rahmatini, G. Aliska, M. Syafri, A. Achyar
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-04-01
Series:	Российский кардиологический журнал
Subjects:	acute coronary syndrome clopidogrel cyp2c19 polymorphism pru
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2659
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Preliminary Data from a Study on Polymorphism RS4244285 of P4502c19 Cytochrome Gene in Patients with Acute Coronary Syndrome, Undergoing Treatment with Dual Antiplatelet Therapy With Clopidogrel and Aspirin
by: Katya Kovacheva, et al.
Published: (2016-09-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

CYP2C19 Phenotype, P2Y12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy
by: Rajiv C. Patel, et al.
Published: (2025-07-01)

CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE
by: A. I. Akhmetova, et al.
Published: (2017-12-01)

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION
by: T. A. Bairova, et al.
Published: (2014-11-01)

Computational drug–drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel
by: Priyadharshini Ananthathandavan, et al.
Published: (2024-12-01)

Polymorphisms of CYP1A1, CYP1A2, CYP19, and SULT1A1 genes in women with early miscarriage
by: I. N. Noskova, et al.
Published: (2019-12-01)

ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
by: S. J. Martsevich
Published: (2016-01-01)

POLYMORPHISMS OF THE CYP1A1, CYP1A2, CYP19, AND SULT1A1 GENES ARE NOT ASSOCIATED WITH INFERTILITY IN WOMEN WITH GENITAL ENDOMETRIOSIS
by: LARISA N. Danilova, et al.
Published: (2018-09-01)

INTERRELATION OF ANTIHYPERTENSIVE EFFECT OF COMBINATION OF VALSARTAN AND AMLODIPINE WITH VARIOUS POLYMORPHIC VARIANTS OF GENES CYP2C9 AND CYP11B2 IN PATIENTS WITH OBESITY
by: K. Yu. Lazarev, et al.
Published: (2018-05-01)

Regional aspects of associations of the CYP2C19 gene polymorphism with coronary atherosclerosis in acute coronary syndrome
by: K. Yu. Nikolaev, et al.
Published: (2018-11-01)

A PCR-lateral flow assay system based on gold magnetic nanoparticles for CYP2C19 genotyping and its clinical applications
by: Yan Xuhong, et al.
Published: (2019-12-01)

NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: K. B. Mirzaev, et al.
Published: (2018-03-01)

Biochemical markers and cells count in peripheral blood in patients with tuberculosis according to CYP2C9 genotype
by: P. B. Antonenko
Published: (2014-04-01)

THE PROTOCOL: INFLUENCE OF THE COMBINATION CARRIAGE СУР2С19*2 AND *17 ON EFFICACY OF CLOPIDOGREL
by: Е. М. Zelenskaya, et al.
Published: (2017-11-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES
by: A. N. Repin, et al.
Published: (2015-10-01)

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms
by: O. G. Gribakina, et al.
Published: (2019-02-01)

Impact of <i>CYP2C9, CYP2C19</i> and <i>ABCB1</i> genetic polymorphisms on antiepileptic drug safety and efficacy
by: N. A. Galankin, et al.
Published: (2025-05-01)

Genetic polymorphism of CYP1A1 and CYP2D6 in populations of Buryats, Teleuts and Russians of Eastern Siberia
by: L. E. Tabikhanova, et al.
Published: (2018-04-01)

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN
by: O. V. Guzeva, et al.
Published: (2016-05-01)

EFFICIENCY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY DEPENDING ON THE POLYMORPHISM OF CYP2C9 GENE
by: F. A. Kovalenko, et al.
Published: (2018-05-01)

GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA
by: K. B. Mirzaev, et al.
Published: (2015-10-01)

CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation
by: A. A. Kurylev, et al.
Published: (2018-05-01)

Modulating effect of Cu(II) complexes with enamine and tetrazole derivatives on CYP2C and CYP3A and their cytotoxic and antiproliferative properties in HepG2 spheroids
by: L. S. Klyushova, et al.
Published: (2022-12-01)

DISTRIBUTION OF POLYMORPHIC VARIANTS OF THE CYP1A1 AND CYP1A2 GENES IN THE MONGOLOID AND CAUCASOID POPULATION OF THE SOUTH OF KUZBASS
by: Фаина Анисимовна Лузина, et al.
Published: (2021-08-01)

Clopidogrel therapy in acute coronary syndrome: Contemporary issues
by: Satyavir Yadav, et al.
Published: (2025-07-01)

Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy
by: Yu Wu, et al.
Published: (2025-12-01)

Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment Outcomes
by: Lauren Varney, et al.
Published: (2025-06-01)

The Effect of Polymorphisms in the CYP2D6 and CYP2C9 Genes on the Clinical Efficacy of Tramadol and Ketorolac When Using the Accelerated Recovery Protocol in Patients With Uncomplicated Acute Calculous Cholecystitis Who Underwent Cholecystectomy
by: A. A. Muradyan, et al.
Published: (2020-10-01)

PERSONALIZED APPROACH TO TREATMENT OF CHRONIC INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT IN CHILDREN WITH CYP2C19 POLYMORPHISM ACCOUNT
by: E. V. Dudnikova, et al.
Published: (2015-12-01)

Clinically significant CYP2C19 genotypes in patients with myocardial infarction in the northern region of Russia
by: A. S. Vorobyov, et al.
Published: (2023-11-01)

Association of CYP19A1 gene polymorphisms with reproductive traits in pigs
by: Rong ZHOU, et al.
Published: (2017-07-01)

Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats
by: V. P. Zherdev, et al.
Published: (2017-11-01)

Association of polymorphic variants of <i>CYP2C19</i>, <i>P2RY12</i>, <i>ITGB3</i>, <i>ITGA2</i> and <i>eNOS3</i> genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction
by: T. P. Pronko, et al.
Published: (2023-07-01)

DIVERSE PEACH ALLERGY: SENSITIZATION TO MOLECULAR COMPONENTS OF ALLERGENS FROM PRUNUS PERSICA
by: M. A. Mokronosova, et al.
Published: (2014-07-01)

Evaluation of the relationship between the minimum steady-state concentration of angiotensin II receptor blockers and polymorphic markers of CYP2C9 (Arg144Cys), CYP2C9 (IlE359Leu), AGTR1 (A1166C), AGT (Met235Thr, C4072T), ACE (I/D), CYP11B2 (C-344T) genes and office arterial pressure
by: E. V. Rebrova, et al.
Published: (2025-03-01)

Predictors of angina pain relapse after coronary stenting for acute coronary syndrome in Buryats
by: E. M. Zelenskaya, et al.
Published: (2023-11-01)

Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024-05-01)